Meropenem Sodium Injection


MERIVA (Meropenem Sodium Inj.) is an ultra broad-spectrum antibiotic, which is generally used as a last resort of antibiotic to treat severe ICU infections. Considering the fact ICU’s are the most vulnerable place for the nosocomial infections and the increase in incidence of resistance to Cephlosporin antibiotics, MERIVA (Meropenem) is an effective alternative to bring respite to both the intensives and the patient fighting against the critical illnesses in ICUs.

  • Septicemia
  • Pneumonia
  • Febrile Neutropenia
  • Urinary tract infections
  • Meningitis
  • Gynecological infections
Product variants & features
Product Strength Presentation
MERIVA 500 mg , 1 gm 500 mg & 1 gm available in Vial with SWFI
  • A wide spectrum of activity against gram + ve , gram – ve & anaerobic orgamisms.
  • Meroepenem penetrates into CSF so used to treat bacterial meningitis.
  • Meropenem is stable against hydroysis by human renal dehydropeptidase (DHP –1) and concomitant administration of cilastatin (DHP inhibitor) is not required.